Effects of Acute Systemic Inflammation on Arterial Stiffness and Microcirculation.
NCT01556373 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 8
Last updated 2019-12-27
Summary
This study aims to assess the effect of acute inflammation on arterial stiffness and microcirculation. Patients with severe sepsis will be compared with age-, sex- and cardiovascular risk factors-matched controls.
The primary outcome is the carotid-femoral pulse wave velocity. The other outcome measures are: systemic hemodynamics (systolic, diastolic, mean and pulse blood pressures, heart rate, cardiac output, left ventricular ejection fraction, systemic vascular resistances), central hemodynamics (aortic systolic, diastolic, mean and pulse pressures, and augmentation index), thenar tissue oxygen saturation, biological makers of inflammation (plasma fibrinogen, C-reactive protein, interleukin-6, matrix metalloproteinases -2, -9, tissue inhibitor of metalloproteinase 1), and plasma catecholamine concentrations (epinephrine, norepinephrine).
Conditions
- Severe Sepsis
Interventions
- OTHER
-
NA : non interventional study
NA : non interventional study
Sponsors & Collaborators
-
Rennes University Hospital
lead OTHER
Principal Investigators
-
Bruno LAVIOLLE, MD, PhD · Rennes University Hospital
-
Eric BELLISSANT, MD, PhD · Rennes University Hospital
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2012-02-23
- Primary Completion
- 2015-04-16
- Completion
- 2015-04-16
Countries
- France
Study Locations
More Related Trials
-
Causes and Factors Associated With Outcomes in Community-acquired Sepsis and Severe Sepsis in Northeast Thailand
NCT02217592 ·Status: COMPLETED
-
Novel Sepsis Sub-phenotypes Based on Trajectories of Vital Signs
NCT05826223 ·Status: COMPLETED
-
Neutropenic Fever, Inflammatory Markers and Sepsis in Haematological Patients
NCT00781040 ·Status: COMPLETED
-
Hemodynamic Evaluation Using Microcirculation for Early Treatment of Septic Patients
NCT06910891 ·Status: RECRUITING ·Phase: NA
-
Study of Procalcitonin (PCT)-Guided Antibiotic Use in Severe Sepsis Patients Without Obvious Infection
NCT01025180 ·Status: TERMINATED ·Phase: PHASE4
-
Procurement of Human Specimens for the Evaluation of Early Markers of Sepsis
NCT01746407 ·Status: COMPLETED
-
Immune Profile of Patients With Sepsis
NCT04163705 ·Status: UNKNOWN
-
Comparative Study of the Protein C Pathway in Septic and Non Septic Patients With Organ Failure
NCT00361725 ·Status: TERMINATED
-
Comparison the Value of Several Biomarkers of Sepsis
NCT01388725 ·Status: COMPLETED
-
Sepsis: From Syndrome to Personalized Care
NCT04203979 ·Status: RECRUITING
-
The Role of NLR in the Diagnosis and Prognosis of Sepsis
NCT05636202 ·Status: COMPLETED
-
Endotoxin Activity Assay and Microcirculation in Severe Sepsis
NCT02452138 ·Status: UNKNOWN
-
Establishment of Early Diagnosis and Monitoring Model for Sepsis Patients
NCT04974411 ·Status: UNKNOWN
-
Study on the Establishment of a System for Early Warning and Prognostic Evaluation of Patients With Sepsis
NCT05229328 ·Status: UNKNOWN
-
A Prospective Observational Study of Sepsis
NCT05309889 ·Status: UNKNOWN
-
Early PREdiction of Severe Sepsis I (ExPRES-Sepsis I) Study
NCT02188992 ·Status: COMPLETED
-
Identification and Clinical Efficacy Analysis of Biomarkers in Sepsis Patients
NCT05911711 ·Status: UNKNOWN
-
Interest of the Balance of Pro-coagulating and Profibrinolytis Activities of the Microparticles (MP) in the Prognosis of Septic Shock
NCT02062970 ·Status: UNKNOWN ·Phase: NA
-
Host Dysregulation-Driven Sepsis Prediction Model
NCT06523075 ·Status: COMPLETED
-
Registration of Sepsis Patients in the Emergency Department
NCT06068192 ·Status: NOT_YET_RECRUITING
-
Risk Factors for Adverse Outcomes in Sepsis
NCT06541600 ·Status: COMPLETED
-
Clinical Research on Shenfu Injection in Septic Patients
NCT06157320 ·Status: RECRUITING ·Phase: NA
-
New Strategy to Predict Early Sepsis
NCT04118179 ·Status: UNKNOWN
-
Mediators of Inflammation, Prognostic Markers and Genetic Polymorphisms in Patients With Sepsis
NCT01535534 ·Status: UNKNOWN
-
Beta-lactam Intermittent Versus Continuous Infusion and Combination Antibiotic Therapy in Sepsis
NCT05681442 ·Status: RECRUITING ·Phase: PHASE4